NorthView Acquisition (NVACR) Short Interest Ratio & Short Volume

Short interest is the volume of NorthView Acquisition shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 24,400 shares of NVACR short. Learn More on NorthView Acquisition's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVACR shares currently have a short interest ratio of 1.0. Learn More on NorthView Acquisition's short interest ratio.

NorthView Acquisition saw a decline in short interest in the month of August. As of August 15th, there was short interest totaling 24,400 shares, a decline of 18.7% from the previous total of 30,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "medical equipment" compare to NorthView Acquisition: Nyxoah S.A. (0.46%), Stevanato Group S.p.A. (7.50%), Zimmer Biomet Holdings, Inc. (3.34%), Solventum Co. (2.61%), Smith & Nephew plc (0.66%), Penumbra, Inc. (4.82%), Glaukos Co. (4.82%), Bausch + Lomb Co. (3.13%), Inspire Medical Systems, Inc. (6.67%), PROCEPT BioRobotics Co. (11.85%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.

Short selling NVACR is an investing strategy that aims to generate trading profit from NorthView Acquisition as its price is falling. NVACR shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NorthView Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVACR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVACR, twice per month. The most recent reporting period available is August, 15 2024.